GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+25.08%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$311M
AUM Growth
+$311M
Cap. Flow
+$122M
Cap. Flow %
39.1%
Top 10 Hldgs %
41.8%
Holding
78
New
28
Increased
24
Reduced
11
Closed
7

Top Buys

1
MLTX icon
MoonLake Immunotherapeutics
MLTX
$11.1M
2
TGTX icon
TG Therapeutics
TGTX
$8.75M
3
APLS icon
Apellis Pharmaceuticals
APLS
$7.64M
4
ROIV icon
Roivant Sciences
ROIV
$7.38M
5
BPMC
Blueprint Medicines
BPMC
$6.9M

Top Sells

1
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$6.76M
2
KRYS icon
Krystal Biotech
KRYS
$6.41M
3
ARGX icon
argenx
ARGX
$5.71M
4
TSHA icon
Taysha Gene Therapies
TSHA
$3.3M
5
GPCR icon
Structure Therapeutics
GPCR
$3.21M

Sector Composition

1 Healthcare 99.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARVN icon
51
Arvinas
ARVN
$580M
$1.65M 0.46%
40,000
-19,250
-32% -$795K
ATXS icon
52
Astria Therapeutics
ATXS
$394M
$1.62M 0.45%
115,000
-220,000
-66% -$3.1M
LRMR icon
53
Larimar Therapeutics
LRMR
$337M
$1.6M 0.44%
+210,603
New +$1.6M
CYTK icon
54
Cytokinetics
CYTK
$5.98B
$1.4M 0.39%
20,000
+10,000
+100% +$701K
CTMX icon
55
CytomX Therapeutics
CTMX
$350M
$1.31M 0.36%
+600,000
New +$1.31M
ELEV
56
DELISTED
Elevation Oncology
ELEV
$1.28M 0.36%
+250,000
New +$1.28M
NGNE icon
57
Neurogene
NGNE
$284M
$1.27M 0.35%
+25,000
New +$1.27M
SGMT icon
58
Sagimet Biosciences
SGMT
$239M
$1.22M 0.34%
+225,000
New +$1.22M
ATYR
59
aTyr Pharma
ATYR
$560M
$1.17M 0.32%
+600,000
New +$1.17M
PMVP icon
60
PMV Pharmaceuticals
PMVP
$82.1M
$1.15M 0.32%
675,000
-50,000
-7% -$85K
ARWR icon
61
Arrowhead Research
ARWR
$3.84B
$1M 0.28%
+35,000
New +$1M
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$3.04B
$934K 0.26%
+20,000
New +$934K
QURE icon
63
uniQure
QURE
$954M
$858K 0.24%
165,000
– –
ANTX icon
64
AN2 Therapeutics
ANTX
$35.3M
$713K 0.2%
+219,331
New +$713K
NTLA icon
65
Intellia Therapeutics
NTLA
$1.26B
$688K 0.19%
+25,000
New +$688K
INBX
66
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-35,000
Closed -$1.33M
AMAM
67
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
– –
-475,000
Closed -$6.76M
CBAY
68
DELISTED
Cymabay Therapeutics
CBAY
– –
-90,000
Closed -$2.13M
ITCI
69
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
0
– –
XBI icon
70
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
VRNA
71
Verona Pharma
VRNA
$9.18B
– –
-30,000
Closed -$596K
RVMD icon
72
Revolution Medicines
RVMD
$7.43B
– –
0
– –
RAPT icon
73
RAPT Therapeutics
RAPT
$187M
– –
0
– –
IWM icon
74
iShares Russell 2000 ETF
IWM
$66.6B
– –
0
– –
BLUE
75
DELISTED
bluebird bio
BLUE
– –
-465,000
Closed -$642K
1 2
3
4